University of Tennessee Health Science Center Campus Photos
OWA WebMail  /  SiteMap  /  Contact Information
College of Medicine

Department of Orthopaedic Surgery

Advancing Musculoskeletal

Discoveries

The Campbell Foundation and Campbell Clinic, with the urging of Memphis Tomorrow and the Memphis Bioworks Foundation, had taken a leading role in the creation of a new type of research facility, one that would continue Memphis' growth as a biomedical powerhouse, and that would align the city's assets in the field of musculoskeletal research and treatment.

InMotion Musculoskeletal Research Institute's (InMotion) goal is to bring translational orthopaedic research to Memphis. Translational research transports innovative research into the clinic, so that patients benefit directly from that research. InMotion's slogan aptly describes its mission: "From research to reality."

The Campbell Foundation, along with the Hyde Family Foundation and the Memphis Bioworks Foundation, has provided start-up money for InMotion. The Campbell Foundation has also provided office space and human resources support for InMotion employees, as well as development expertise to fund the institute's research.

At full strength, InMotion will provide a nexus of collaborative efforts among orthopaedic surgeons and researchers who might not have worked together in other settings. Plans for InMotion include providing research and development for orthopaedic technology companies such as Smith & Nephew, Medtronic Sofamor Danek, DePuy Orthopaedics, and Wright Medical Group, as well as education efforts such as assisting UT-Campbell Clinic in training its residents in research design.

MMRI Goes InMotion

The Memphis Musculoskeletal Research Institute has changed its name to the InMotion Musculoskeletal Institute. This new name reflects InMotion's mission to reduce disability and to improve mobility for the musculoskeletal patient through translational research. "The new name conveys the excitement, enthusiasm, and commitment that the Memphis community has brought to this endeavor," says Dick Tarr, InMotion Executive Director. "The collaboration between InMotion and local universities, hospitals, clinics and industry provides a new paradigm for translational medicine by effectively and efficiently forming partnerships to move research to reality in the care of the musculoskeletal patient."

Board of Directors

  • Dr. Steven J. Bares, President and Executive Director of the Memphis Bioworks Foundation;
  • Dr. James H. Beaty, Chief of Staff, Campbell Clinic and Professor of the UT-Campbell Clinic Department of Orthopaedic Surgery;
  • Jack Blair, former Smith & Nephew group president of North America and Japan;
  • Dr. S. Terry Canale, Boyd Professor and Chair of the UT-Campbell Clinic Department of Orthopaedic Surgery;
  • Dr. Leonard "Rusty" Johnson, Professor and Interim Vice Chancellor of Research at the University of Tennessee Health Science Center
  • J. R. "Pitt" Hyde, III, founder of AutoZone;
  • Dr. Shirley Raines, President of the University of Memphis; and
  • Jon Serbousek, President of Medtronic Sofamor Danek

Did You Know?

Approximately one in five adults has doctor-diagnosed arthritis?

A fracture requiring orthopaedic treatment occurs about every 14 seconds?

Musculoskeletal disorders and conditions are the #1 cause of disability, worldwide?

Richard R. Tarr, Executive Director

Richard R. Tarr was DePuy's Vice President of Worldwide Research and Emerging Technologies prior to retiring on July 1, 2005, after 20 years of continuous service. Mr. Tarr was responsible for DePuy's worldwide research initiatives to bring new technology products to market, particularly in the emerging technologies area. He was directly responsible for the new 50,000 sq. ft. research facilities in Warsaw, Indiana, which were opened and dedicated in September 2003.

Tarr joined DePuy in 1985 and progressed through research and development holding positions of Director, Hip, Extremities, Sports Medicine, Operating Room and Trauma Product Development; General Manager, DePuy DuPont Orthopaedics; Vice President, R&D; Senior Vice President, R&D; Chief Technology Officer; Vice President, Worldwide Research and Orthobiologics, and finally, Vice President, Worldwide Research and Emerging Technologies.

Mr. Tarr holds five patents on orthopaedic products and instruments and frequently speaks and publishes on orthopaedic research topics.